Importantly, we demonstrated that the combination of shACSL3-AAV with IKE has excellent synergistic antitumor effects in radioresistant tumor cells response to RT, suggesting that targeting ACSL3 and inducing ferroptosis cooperate to resensitize radioresistant cancer cells to radiation, suggesting a promising prospect for future clinical translation. This evidence concerns the gene ACSL3 and cancer.